INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 35 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,049,000 | +46.7% | 100,441 | -75.0% | 0.12% | +20.6% |
| Q3 2017 | $715,000 | -6.3% | 401,764 | 0.0% | 0.10% | -21.5% |
| Q2 2017 | $763,000 | -5.1% | 401,764 | 0.0% | 0.13% | -17.2% |
| Q1 2017 | $804,000 | -67.2% | 401,764 | 0.0% | 0.16% | -74.7% |
| Q4 2016 | $2,451,000 | -35.7% | 401,764 | 0.0% | 0.62% | 0.0% |
| Q3 2016 | $3,809,000 | +104.8% | 401,764 | +60.7% | 0.62% | +28.4% |
| Q2 2016 | $1,860,000 | +0.5% | 250,000 | 0.0% | 0.48% | +20.4% |
| Q1 2016 | $1,850,000 | -54.6% | 250,000 | -30.6% | 0.40% | -32.8% |
| Q4 2015 | $4,079,000 | +47.1% | 360,000 | +22.0% | 0.60% | +68.6% |
| Q3 2015 | $2,773,000 | +48.9% | 295,000 | -22.4% | 0.35% | +94.5% |
| Q2 2015 | $1,862,000 | -14.1% | 380,000 | -5.0% | 0.18% | -19.5% |
| Q1 2015 | $2,168,000 | – | 400,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,802,000 | $3,207,000 | 1.13% |
| SENZAR ASSET MANAGEMENT, LLC | 781,922 | $1,392,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 401,764 | $715,000 | 0.10% |
| FT Options LLC | 20,000 | $36,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 367,300 | $654,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,731 | $249,000 | 0.04% |
| FT Options LLC | 14,900 | $7,000 | 0.01% |
| MERIDIAN INVESTMENT COUNSEL INC. | 20,000 | $37,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,500,000 | $2,670,000 | 0.01% |
| Point72 Asset Management, L.P. | 635,465 | $1,131,000 | 0.01% |